BioCentury
ARTICLE | Clinical News

QR-333: Final phase IIb data

July 27, 2009 7:00 AM UTC

Final data in 140 evaluable patients in a double-blind, placebo-controlled Phase IIb trial showed that QR-333 missed the primary and secondary endpoints of significant differences in reduced pain, imp...